News Conference News Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags L.A. McKeown September 10, 2020
News Daily News Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests Todd Neale August 03, 2020
News Daily News Higher Risk of HF After ACS for Women Previously on Beta-blockers Michael O'Riordan July 16, 2020
News Daily News Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects Michael O'Riordan July 13, 2020
News Daily News Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly Michael O'Riordan July 06, 2020
News Daily News Renal Denervation Lowers BP Across High-risk Groups: Global SYMPLICITY Registry Todd Neale June 09, 2020
News Daily News COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill Michael O'Riordan May 19, 2020
News Features Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes Michael O'Riordan May 12, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Daily News Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated L.A. McKeown May 05, 2020
News Daily News Cardiac Injury in COVID-19 Sharply Increases Risk of Death Caitlin E. Cox March 26, 2020
News Daily News Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease Michael O'Riordan March 13, 2020
News Daily News Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication Michael O'Riordan January 17, 2020
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019